Proving the Business Case for the Internet of Things

Bluetooth improves Parexel active tracking service

Steve Rogerson
November 8, 2017



Parexel has enhanced its active tracking service with Bluetooth capability to improve monitoring of temperature-controlled medication. The feature uses mobile and sensor technology via the Massachusetts company’s ClinPhone RTSM mobile app to prevent temperature-compromised medication from reaching clinical trial patients.
 
The ClinPhone RTSM (randomisation and trial supply management) mobile app addresses the workflow and safety issues commonly associated with the packaging, transport and storage of temperature-sensitive medications. The capability will provide end-to-end temperature monitoring that records the complete temperature history of a product from the point of packaging through to patient dispensation via in-pack wireless sensors.
 
The offering meets a growing need for the biopharmaceutical industry to manage the increasing number of critically temperature-sensitive medications being evaluated in clinical trials. By 2020, it is expected that eight out of the top ten global biopharmaceutical products will require cold-chain management.
 
Research has shown that most temperature excursions impacting medications occur during storage at the clinical site. Using wireless sensors combined with the RTSM service, sites and logistics teams can track temperatures from the point of secondary packaging through dispensation to the patient.
 
“At Parexel, we continually innovate to better ensure patient safety and data accuracy while simplifying tasks for clinical trial sites,” said Ubavka DeNoble, corporate vice president for Parexel. “This important new functionality builds on the existing capabilities of Parexel’s active tracking service and the ClinPhone RTSM mobile app to better manage the chain of custody record for clinical supplies. For treatments that require cold-chain handling, just a few degrees can make a huge difference, potentially impacting the safety of the medication, leading to the risk of the drug being unavailable for the next patient visit or affecting patient safety. With this new offering, clients will reduce safety risks and costs associated with temperature-compromised stock.”
 
The feature was demonstrated last month during the CBI’s seventh annual Interactive Response Technologies in Clinical Trials conference in Philadelphia. It is the latest addition to Parexel’s Connected Journey of more than 40 data-driven services, and is available via the ClinPhone RTSM mobile app.
 
The RTSM service has been deployed on more than 4000 studies and more than 2.5 million patients, with the largest of those studies randomising and supplying more than 60,000 patients. The active tracking service controls and monitors the distribution of clinical trial supplies through its clinical trial supplies and logistics experts and global network of over 50 GMP compliant depots. The app is available worldwide for use on Android and iOS platforms.
 
Headquartered near Boston, Massachusetts, Parexel has around 18,900 employees with offices in 85 locations in 52 countries.